Binayak Upadhyay

Binayak Upadhyay practices at Mount Sinai Hospital in Chicago, Illinois, part of Sinai Health System.

Binayak Upadhyay's NPI, 1548756703, was assigned on July 10, 2018. Binayak Upadhyay holds Kentucky license 55291.

Binayak Upadhyay's primary practice is Mount Sinai Hospital, at 15th Street at California, Chicago, IL 60608 in Cook County. The practice phone is (773) 542-2000. Binayak Upadhyay also practices at Mount Sinai Hospital Medical Center, 1500 S Fairfield Ave, Chicago, IL 60608.

Binayak Upadhyay's primary practice is Mount Sinai Hospital in Chicago, Illinois, part of Sinai Health System. The medical group on file is Sinai Medical Group. Dmand AI also links Binayak Upadhyay to 1 more breast imaging center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Binayak Upadhyay practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Binayak Upadhyay's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Binayak Upadhyay is licensed in Kentucky.

CMS data shows 359 Medicare services from Binayak Upadhyay across 4 procedure codes in 2024, for 110 Medicare patients. Medicare paid $32,549 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 110 Medicare patients who saw Binayak Upadhyay in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 59% are also on Medicaid. Their average risk score is 3.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Binayak Upadhyay's median patient age at 73, with 60% women.

In 2024, Binayak Upadhyay wrote 109 Medicare Part D claims for 32 patients. 80% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $114 in total drug cost. In 2022, CMS named 30 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Binayak Upadhyay for performance year 2024, reported as part of a group.

CMS Open Payments shows 4 general payments to Binayak Upadhyay from 4 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Ethicon Inc. paid the most, $34.